GE Healthcare and Indi Molecular to collaborate on diagnostic tool for clinical management of immunotherapy patients
Chalfont St Giles, UK & Culver City, CA, May 14 2019 – GE Healthcare and Indi Molecular, Inc, a California-based biotechnology company, have announced plans to develop immune cell-targeted Positron-Emission Tomography (PET) tracer candidates, based on Indi Molecular’s proprietary Protein Catalyzed Capture (PCC) technology. These tracer candidates, if successful, could help identify molecular markers of cytotoxic T-cells,... Read more